financetom
Business
financetom
/
Business
/
HubSpot Chief Customer Officer Rob Giglio Departs
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
HubSpot Chief Customer Officer Rob Giglio Departs
Apr 16, 2024 2:08 PM

04:32 PM EDT, 04/16/2024 (MT Newswires) -- HubSpot ( HUBS ) said Tuesday Chief Customer Officer Rob Giglio left the company on Friday.

A successor won't be appointed, and leaders of sales, marketing and customer success will report directly to Chief Executive Officer Yamini Rangan, the company said.

Shares of the company fell 0.2% in after-hours trading.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-IR-Med Intends To Apply To List Common Stock And Warrants On Nasdaq Capital Market
BRIEF-IR-Med Intends To Apply To List Common Stock And Warrants On Nasdaq Capital Market
Jun 24, 2024
June 24 (Reuters) - IR-MED Inc ( IRME ): * IR-MED INC ( IRME ) -INTEND TO APPLY TO LIST COMMON STOCK AND WARRANTS ON NASDAQ CAPITAL MARKET UNDER SYMBOLS IRME AND IRMEW, RESPECTIVELY Source text for Eikon: Further company coverage: ...
Martin Midstream Works With EPA, Others to Contain Spill in Arkansas; Shares Fall After Hours
Martin Midstream Works With EPA, Others to Contain Spill in Arkansas; Shares Fall After Hours
Jun 24, 2024
05:45 PM EDT, 06/24/2024 (MT Newswires) -- Martin Midstream Partners ( MMLP ) said late Monday it is working with the US Environmental Protection Agency, Arkansas Department of Energy and Environment, and Arkansas Game and Fish Commission to respond to a spill of about 2,000 barrels of crude oil. The spill originated from the company's transfer pipeline that connects its...
VTv Therapeutics Announces Screening of First Patient in Trial of Cadisegliatin for Type 1 Diabetes
VTv Therapeutics Announces Screening of First Patient in Trial of Cadisegliatin for Type 1 Diabetes
Jun 24, 2024
05:50 PM EDT, 06/24/2024 (MT Newswires) -- VTv Therapeutics ( VTVT ) said Monday the first patient was screened in a trial of cadisegliatin as an adjunct treatment of type 1 diabetes. The registrational study will form the core of the regulatory submission for cadisegliatin, vTv said. The study will evaluate the safety and efficacy of cadisegliatin over 12 months...
Hess CEO to join Goldman Sachs board as independent director
Hess CEO to join Goldman Sachs board as independent director
Jun 24, 2024
NEW YORK, June 24 (Reuters) - John Hess, CEO of Hess Corp ( HES ), has joined the board of Goldman Sachs ( GS ) as independent director, the Wall Street firm said on Monday. He is the latest addition to the board after senior banking executive Tom Montag joined as an independent director last year. He will also become...
Copyright 2023-2026 - www.financetom.com All Rights Reserved